Aggressive blood pressure managementtargeting a systolic blood pressure (SBP) less than 120 mm Hgis associated with much better cardiovascular outcomes than taking a more traditional approach, according to new findings published in the New England Journal of Medicine. The analysis represented a fresh look at data from the SPRINT study, which was originally completed back in 2015. Researchers were able to include additional data in this update, including new findings from an observational post-intervention period. Continue reading →

During the 4th Annual University of Utah Translational Hypertension Symposium, there was a discussion about the inequities in health care for the diagnosis and management of hypertension in the United States and how these inequities have been exacerbated by the COVID-19 pandemic. A synopsis of this discussion was published in the Journal of the American Heart Association. Continue reading →

To conduct research and analysis, and deliver accurate and reliable forecasts on all global markets, a DBMR team of experts and professionals from various streams and verticals bring along crucial tried-and-tested skills, approaches, and techniques. Cardiac Marker Testing Market report is spread across several pages and provides newest industry data, market future trends that allows identification of the products and end users driving revenue growth and profitability. The comprehensive business report analyses and examines the important industry trends, market size, market share estimates, and sales volume with which businesses can guess the strategies to increase their return on investment (ROI). Continue reading →

Cardiovascular diseases are estimated to kill around 18 million people annually, earning them a top seat among the leading causes of death globally. Studying the diseases of this vital organ has been a tricky task as finding a suitable model (we cant very well go tinkering with volunteers life pumps) for research. Continue reading →

A new market study report by The Insight Partners on the Myocardial Infarction Therapeutics Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. Continue reading →

DUBLIN, May 21, 2021 /PRNewswire/ -- The "Cell Therapy - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine Continue reading →

A systolic blood pressure (SBP) reduction of 4.5 mm Hg is not good enoughfor an invasive procedure. At the virtual American College of Cardiology (ACC) 2021 Scientific Session, Ajay Kirtane, MD, from Columbia University in New York City, presented the results of RADIANCE-HTN TRIO Continue reading →

Hi-Tech Pharmaceuticals is recalling 1 lot of Lipodrene w/25mg Ephedra Extract Dietary Supplement due to the presence of 1,4-dimethylamylamine (DMAA). Continue reading →